chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Chills, Pain, Rash, Urticaria
Clinical narrative: "I" developed a rash on the 4th day and then hives. The hives woke me up at 2am on 4/27.; "I" developed a rash on the 4th day; "I" experienced chills and aches for 3.5 to 4 days; "I" experienced chills and aches for 3.5 to 4 days; Soreness in left "my" armpit; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 22Apr2021 at 12:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The medical history included moles removed, benign thyroid nodule and half of thyroid removed. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The concomitant medications included levothyroxine sodium (UNITHROID), ascorbic acid (VITAMIN C), multivitamin(unspecified), sambucus nigra fruit (ELDERBERRY) and vitamin d nos (VITAMIN D); all for an unknown indications from unknown dates and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 12:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On an unknown date in Apr2021, the patient experienced chills and aches for 3.5 to 4 days, including soreness in left armpit. On 26Apr2021, the 4th day the patient developed a rash. On 27Apr2021 at 02:00, the hives woke the patient up. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of hives included treatment with diphenhydramine hydrochloride (BENADRYL) and cetirizine hydrochloride (ZYRTEC). Since, the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills and aches were resolved on unknown date in Apr2021, while the clinical outcome of the event soreness in left armpit was unknown at the time of this report. The clinical outcome of the events rash and hives were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: 36 hours after my shot I experience a mild frontal headache; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EER8730) via an unspecified route of administration in the right arm on 25Apr2021 at 12:30 (at the age of 57-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history and had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 04Apr2021 at 12:00 (at the age of 57-year-old), as a single dose for COVID-19 immunisation. On 26Apr2021 at 00:00, 36 hours after shot, the patient experienced mild frontal headache which lasted most of the day until after dinner. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event mild frontal headache was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Intermenstrual bleeding
Clinical narrative: Menstrual spotting following the first shot of the vaccine; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 19Apr2021 at 09:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 19Apr2021, the patient experienced menstrual spotting following the first shot of the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event menstrual spotting following the first shot of the vaccine was recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Burning sensation, Chills, Headache, Lethargy
Clinical narrative: Extreme leg, hip foot pain; Extreme leg, hip foot pain; Extreme leg, hip foot pain; Muscle aches that moved uno and down; Tingling; Burning sensation in foot, toes; Now have several bumps appear near a tick bite from last summer; Tennis ball size swelling in arm; Headache; Extreme, deep body ache; Chills; Lethargy; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 06Apr2021 at 10:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included suspected COVID-19 on Jan2020. The patient did not have any known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included ascorbic acid (VITAMIN C), vitamin b complex (VITAMIN B), tocopherol (VITAMIN E), vitamin D nos (VITAMIN D), magnesium glycinate (MANUFACTURER UNKNOWN) and collagen (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. On 06Apr2021 at 22:00, the patient experienced tennis ball size swelling in arm, headache, extreme, deep body ache, chills, lethargy first 3 days then was slowly subsiding, had muscle aches that moved up and down, tingling, burning sensation in foot, toes that lasted about a week then subsiding and also had several bumps appear near a tick bite from last summer. On 16Apr2021, 10 days later, the patient had extreme leg, hip foot pain. It was reported that the patient walks about 5 miles a day, eat a vegetarian diet, take vitamins & know body well, the patient rarely caught colds/ flu but the patient believe that she had COVID-19 in Jan 2020. It was reported that the patient was concerned about taking a second dose of vaccination after the pronounced reaction to 1st dose of COVID vaccine injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling in the arm, headache, extreme, deep body ache, chills, lethargy and extreme leg, hip foot pain, had muscle aches that moved up and down, tingling, burning sensation in foot, toes and now have several bumps were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pain in extremity, Paraesthesia, Peripheral swelling
Clinical narrative: Extreme leg, hip foot pain; Extreme leg, hip foot pain; Extreme leg, hip foot pain; Muscle aches that moved uno and down; Tingling; Burning sensation in foot, toes; Now have several bumps appear near a tick bite from last summer; Tennis ball size swelling in arm; Headache; Extreme, deep body ache; Chills; Lethargy; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 06Apr2021 at 10:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included suspected COVID-19 on Jan2020. The patient did not have any known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included ascorbic acid (VITAMIN C), vitamin b complex (VITAMIN B), tocopherol (VITAMIN E), vitamin D nos (VITAMIN D), magnesium glycinate (MANUFACTURER UNKNOWN) and collagen (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. On 06Apr2021 at 22:00, the patient experienced tennis ball size swelling in arm, headache, extreme, deep body ache, chills, lethargy first 3 days then was slowly subsiding, had muscle aches that moved up and down, tingling, burning sensation in foot, toes that lasted about a week then subsiding and also had several bumps appear near a tick bite from last summer. On 16Apr2021, 10 days later, the patient had extreme leg, hip foot pain. It was reported that the patient walks about 5 miles a day, eat a vegetarian diet, take vitamins & know body well, the patient rarely caught colds/ flu but the patient believe that she had COVID-19 in Jan 2020. It was reported that the patient was concerned about taking a second dose of vaccination after the pronounced reaction to 1st dose of COVID vaccine injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling in the arm, headache, extreme, deep body ache, chills, lethargy and extreme leg, hip foot pain, had muscle aches that moved up and down, tingling, burning sensation in foot, toes and now have several bumps were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Skin disorder
Clinical narrative: Extreme leg, hip foot pain; Extreme leg, hip foot pain; Extreme leg, hip foot pain; Muscle aches that moved uno and down; Tingling; Burning sensation in foot, toes; Now have several bumps appear near a tick bite from last summer; Tennis ball size swelling in arm; Headache; Extreme, deep body ache; Chills; Lethargy; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 06Apr2021 at 10:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included suspected COVID-19 on Jan2020. The patient did not have any known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included ascorbic acid (VITAMIN C), vitamin b complex (VITAMIN B), tocopherol (VITAMIN E), vitamin D nos (VITAMIN D), magnesium glycinate (MANUFACTURER UNKNOWN) and collagen (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. On 06Apr2021 at 22:00, the patient experienced tennis ball size swelling in arm, headache, extreme, deep body ache, chills, lethargy first 3 days then was slowly subsiding, had muscle aches that moved up and down, tingling, burning sensation in foot, toes that lasted about a week then subsiding and also had several bumps appear near a tick bite from last summer. On 16Apr2021, 10 days later, the patient had extreme leg, hip foot pain. It was reported that the patient walks about 5 miles a day, eat a vegetarian diet, take vitamins & know body well, the patient rarely caught colds/ flu but the patient believe that she had COVID-19 in Jan 2020. It was reported that the patient was concerned about taking a second dose of vaccination after the pronounced reaction to 1st dose of COVID vaccine injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling in the arm, headache, extreme, deep body ache, chills, lethargy and extreme leg, hip foot pain, had muscle aches that moved up and down, tingling, burning sensation in foot, toes and now have several bumps were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pain, Pruritus, Pyrexia
Clinical narrative: Fever of 103F; Body aches; Extreme Fatigue; Extreme itchiness on face and neck; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 19Apr2021 at 09:15 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. The patient had just seasonal tree pollen allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 29Mar2021 at 09:15 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. On 19Apr2021 at 19:00, the patient experienced fever of 103F, body aches, extreme fatigue, and extreme itchiness on face and neck with no airway compromise. On the same day, the patient underwent body temperature test and the result was 103 degrees Fahrenheit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever of 103F, body aches, extreme fatigue, and extreme itchiness on face and neck with no airway compromise was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Diarrhoea, Fatigue, Illness, Myalgia
Clinical narrative: Weird feeling in the left side of my mouth, felt like i just left the dentist's; Sore arm; 2 day fever; Muscle soreness; Fatigue; Sore throat; Upset stomach; Diarrhea; Sick for 4 days; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 07Apr2021 at 10:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included  gestational thrombocytopenia. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications in two weeks of vaccination. On 07Apr2021 at 00:00, the patient experienced weird feeling in the left side of her mouth, felt like she just left the dentist's. The patient had gestational thrombocytopenia with 3 pregnancies so she was concerned, especially since the center did not give her a side effects sheet. Other than that sore arm, 2 days fever, muscle soreness, fatigue, sore throat, upset stomach, diarrhea, and was sick for 4 days, probiotics helped. The patient would take second dose but was very apprehensive, figured she would chime in as her past issues with the thrombocytopenia. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of events weird feeling in the left side of her mouth, felt like she just left the dentist's, sore arm, 2 days fever, muscle soreness, fatigue, and sore throat. Therapeutic measures were taken as a result of events upset stomach, diarrhea, and was sick for 4 days, which included treatment with probiotics which helped. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events weird feeling in the left side of her mouth, felt like she just left the dentist's, sore arm, muscle soreness, fatigue, sore throat, upset stomach, and diarrhea were recovered on an unknown date in Apr2021. The clinical outcome of the events 2 days fever was recovered on 09Apr2021 and sick for 4 days was recovered on 11Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Oral disorder, Oropharyngeal pain, Pain in extremity, Pyrexia
Clinical narrative: Weird feeling in the left side of my mouth, felt like i just left the dentist's; Sore arm; 2 day fever; Muscle soreness; Fatigue; Sore throat; Upset stomach; Diarrhea; Sick for 4 days; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 07Apr2021 at 10:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included  gestational thrombocytopenia. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications in two weeks of vaccination. On 07Apr2021 at 00:00, the patient experienced weird feeling in the left side of her mouth, felt like she just left the dentist's. The patient had gestational thrombocytopenia with 3 pregnancies so she was concerned, especially since the center did not give her a side effects sheet. Other than that sore arm, 2 days fever, muscle soreness, fatigue, sore throat, upset stomach, diarrhea, and was sick for 4 days, probiotics helped. The patient would take second dose but was very apprehensive, figured she would chime in as her past issues with the thrombocytopenia. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of events weird feeling in the left side of her mouth, felt like she just left the dentist's, sore arm, 2 days fever, muscle soreness, fatigue, and sore throat. Therapeutic measures were taken as a result of events upset stomach, diarrhea, and was sick for 4 days, which included treatment with probiotics which helped. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events weird feeling in the left side of her mouth, felt like she just left the dentist's, sore arm, muscle soreness, fatigue, sore throat, upset stomach, and diarrhea were recovered on an unknown date in Apr2021. The clinical outcome of the events 2 days fever was recovered on 09Apr2021 and sick for 4 days was recovered on 11Apr2021.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Ear pain
Clinical narrative: Intermittent pain in right ear; This is a spontaneous report from a contactable consumer, the patient. A female patient of an unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 18Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced intermittent pain in right ear. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event intermittent pain in right ear was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Excessive swelling in L side cervical and supraclavicular lymph nodes; Excessive swelling in L side cervical and supraclavicular lymph nodes; Excessive swelling in L side cervical and supraclavicular lymph nodes with pain.; This is a spontaneous report from a contactable nurse, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 26Apr2021 at 10:45 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified OTC prenatals (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 07Apr2021 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient previously received morphine (MANUFACTURER UNKNOWN), tramadol (MANUFACTURER UNKNOWN) and codeine (MANUFACTURER UNKNOWN) on unknown dates for unknown indications and experienced drugs allergy. The patient did not receive other vaccines within four weeks prior to the vaccination. On 27Apr2021 at 20:30, the patient experienced excessive swelling in left side cervical and supraclavicular lymph nodes with pain. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events excessive swelling in left side cervical and supraclavicular lymph nodes with pain was unknown at the time of this time.  No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Asthenia, Cold sweat, Diarrhoea, Nausea
Clinical narrative: Lack of energy; Nausea; Diarrhea; Stomach cramps; Cold sweats; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8733) via an unspecified route of administration in the right arm on 30Mar2021 at 15:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis (RA). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took dextropropoxyphene hydrochloride (DARVON), codeine (MANUFACTURER UNKNOWN) and paracetamol/oxycodone hydrochloride/oxycodone terephthalate (PERCOCET) and experienced drug allergy. On 30Mar2021 at 20:00, the patient experienced lack of energy, nausea, diarrhea, stomach cramps and cold sweats. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events lack of energy, nausea, diarrhea, stomach cramps and cold sweats was resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest discomfort, Chest pain, Decreased appetite, Fatigue
Clinical narrative: Headache; Severe body pain all over in muscles; Severe body pain all over in muscles, joints; Severe body pain all over in muscles, joints, skin; Severe body pain all over in muscles, joints, skin, nails; Extremely cold; Sweating profusely; Neck pain; Arm pain; Chest pain; Chest pressure; Fatigue; Loss of appetite; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 20Apr2021 at 16:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic leukemia, epstein-barr, chronic fatigue and anxiety. The patient had known allergies to contrast. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications for an unknown indication from an unknown date and unknown if ongoing. The patient previously received ciprofloxacin (MANUFACTURER UNKNOWN) and inosine (BIOXIN); both taken for unknown indications and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 30Mar2021 at 15:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. On 20Apr2021 at 22:00, the patient experienced headache, sever body pain all over in muscles, joints, skin, nails, extremely cold, then sweating profusely, neck pain, arm pain, chest pain, chest pressure, fatigue and loss of appetite. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, sever body pain all over in muscles, joints, skin, nails, extremely cold, sweating profusely, neck pain, arm pain, chest pain, chest pressure, fatigue and loss of appetite was resolved with sequelae on an unknown date in Apr2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Headache, Hyperhidrosis, Myalgia, Neck pain
Clinical narrative: Headache; Severe body pain all over in muscles; Severe body pain all over in muscles, joints; Severe body pain all over in muscles, joints, skin; Severe body pain all over in muscles, joints, skin, nails; Extremely cold; Sweating profusely; Neck pain; Arm pain; Chest pain; Chest pressure; Fatigue; Loss of appetite; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 20Apr2021 at 16:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic leukemia, epstein-barr, chronic fatigue and anxiety. The patient had known allergies to contrast. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications for an unknown indication from an unknown date and unknown if ongoing. The patient previously received ciprofloxacin (MANUFACTURER UNKNOWN) and inosine (BIOXIN); both taken for unknown indications and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 30Mar2021 at 15:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. On 20Apr2021 at 22:00, the patient experienced headache, sever body pain all over in muscles, joints, skin, nails, extremely cold, then sweating profusely, neck pain, arm pain, chest pain, chest pressure, fatigue and loss of appetite. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, sever body pain all over in muscles, joints, skin, nails, extremely cold, sweating profusely, neck pain, arm pain, chest pain, chest pressure, fatigue and loss of appetite was resolved with sequelae on an unknown date in Apr2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Onychalgia, Pain in extremity, Pain of skin
Clinical narrative: Headache; Severe body pain all over in muscles; Severe body pain all over in muscles, joints; Severe body pain all over in muscles, joints, skin; Severe body pain all over in muscles, joints, skin, nails; Extremely cold; Sweating profusely; Neck pain; Arm pain; Chest pain; Chest pressure; Fatigue; Loss of appetite; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 20Apr2021 at 16:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic leukemia, epstein-barr, chronic fatigue and anxiety. The patient had known allergies to contrast. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications for an unknown indication from an unknown date and unknown if ongoing. The patient previously received ciprofloxacin (MANUFACTURER UNKNOWN) and inosine (BIOXIN); both taken for unknown indications and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 30Mar2021 at 15:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. On 20Apr2021 at 22:00, the patient experienced headache, sever body pain all over in muscles, joints, skin, nails, extremely cold, then sweating profusely, neck pain, arm pain, chest pain, chest pressure, fatigue and loss of appetite. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, sever body pain all over in muscles, joints, skin, nails, extremely cold, sweating profusely, neck pain, arm pain, chest pain, chest pressure, fatigue and loss of appetite was resolved with sequelae on an unknown date in Apr2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Nausea, Ovarian cyst
Clinical narrative: Headache; Dizziness; Fatigue; Nausea; Soreness/Possible (Left) Ovarian Cyst; Soreness/Possible (Left) Ovarian Cyst.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 08Apr2021 at 13:30(at the age of 63-years-old) as a single dose for COVID-19 immunisation. The medical history included hypertension, irritable bowel syndrome (IBS), anxiety and seasonal allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included propranolol (MANUFACTURER UNKNOWN), ibuprofen (ADVIL) and ALIVE womens multi, all for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 18Mar2021 at 13:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. On 08Apr2021 at 13:45, the patient experienced headache, dizziness, fatigue, nausea and soreness/possible (left) ovarian cyst. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the events headache, dizziness, fatigue, nausea and soreness/possible (left) ovarian cyst were not resolved at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Headache; Dizziness; Fatigue; Nausea; Soreness/Possible (Left) Ovarian Cyst; Soreness/Possible (Left) Ovarian Cyst.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 08Apr2021 at 13:30(at the age of 63-years-old) as a single dose for COVID-19 immunisation. The medical history included hypertension, irritable bowel syndrome (IBS), anxiety and seasonal allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included propranolol (MANUFACTURER UNKNOWN), ibuprofen (ADVIL) and ALIVE womens multi, all for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 18Mar2021 at 13:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. On 08Apr2021 at 13:45, the patient experienced headache, dizziness, fatigue, nausea and soreness/possible (left) ovarian cyst. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the events headache, dizziness, fatigue, nausea and soreness/possible (left) ovarian cyst were not resolved at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Vaccination site pain
Clinical narrative: Systemic adverse reactions (grade 3, defined as interfering with daily activity), including fatigue; Systemic adverse reactions (grade 3, defined as interfering with daily activity), including muscle pain; Systemic adverse reactions (grade 3, defined as interfering with daily activity), including chills; Systemic adverse reactions (grade 3, defined as interfering with daily activity), including injection site pain; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8BS) via an unspecified route of administration in the right arm on 24Apr2021 at 14:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 27Mar2021 at 16:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 25Apr2021 at 10:00, the patient experienced systemic adverse reactions (grade 3, defined as interfering with daily activity), including fatigue, muscle pain, chills and injection site pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fatigue, muscle pain, chills and injection site pain was resolving at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary mass, Axillary pain, Back pain, Insomnia
Clinical narrative: Tennis ball- sized painful lump underarm.; Tennis ball- sized painful lump underarm.; Stiff neck; Pain in shoulders; Pain in upper back; Insomnia; Sore arm at injection area; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ELV0171) via an unspecified route of administration in the left arm on 23Apr2021 at 17:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included cyproterone acetate / ethinylestradiol (DIANE) for birth control, fluoxetine (MANUFACTURER UNKNOWN), bromazepam (MANUFACTURER UNKNOWN) and methocarbamol (ROBAXIN); for an unknown indication from unknown date and unknown if ongoing. The patient previously received the first dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9261) via an unspecified route of administration in the right arm on 26Mar2021 at 11:15 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 22:00, the patient experienced sore arm at injection area. On 24Apr2021 at 22:00, 24 hours after the vaccination, the patient experienced tennis ball- sized painful lump underarm. Then on 23Apr2021 at 22:00, the patient experienced stiff neck, pain in shoulders and upper back, and insomnia the following 3 days. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment with ice packs, ibuprofen (MANUFACTURER UNKNOWN) and ketorolac (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm at injection area, tennis ball- sized painful lump underarm, stiff neck, pain in shoulders and upper back and insomnia was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Vaccination site pain
Clinical narrative: Tennis ball- sized painful lump underarm.; Tennis ball- sized painful lump underarm.; Stiff neck; Pain in shoulders; Pain in upper back; Insomnia; Sore arm at injection area; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ELV0171) via an unspecified route of administration in the left arm on 23Apr2021 at 17:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included cyproterone acetate / ethinylestradiol (DIANE) for birth control, fluoxetine (MANUFACTURER UNKNOWN), bromazepam (MANUFACTURER UNKNOWN) and methocarbamol (ROBAXIN); for an unknown indication from unknown date and unknown if ongoing. The patient previously received the first dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9261) via an unspecified route of administration in the right arm on 26Mar2021 at 11:15 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 22:00, the patient experienced sore arm at injection area. On 24Apr2021 at 22:00, 24 hours after the vaccination, the patient experienced tennis ball- sized painful lump underarm. Then on 23Apr2021 at 22:00, the patient experienced stiff neck, pain in shoulders and upper back, and insomnia the following 3 days. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment with ice packs, ibuprofen (MANUFACTURER UNKNOWN) and ketorolac (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm at injection area, tennis ball- sized painful lump underarm, stiff neck, pain in shoulders and upper back and insomnia was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Tingling feeling on back of hands,part of forearms; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot Number: EW0176) via an unspecified route of administration in the right arm on 27Apr2021 at 17:45 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and known allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included duloxetine (MANUFACTURER UNKNOWN), for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 27Apr2021 at 18:15, the patient experienced tingling feeling on back of hands, part of forearms. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of the event. The clinical outcome of the event tingling feeling on back of hands, part of forearms was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Diarrhoea, Feeling abnormal, Limb discomfort, Lymphadenopathy
Clinical narrative: Swollen hands and feet; Tight sensation and discomfort in back of legs/ heaviness in my feet and lower legs; Swollen gland in right armpit; Nausea; Burning sensation in back; Pain in injection site; ''I'' have experienced tingling, tightness and heaviness in ''my'' feet and lower legs.; ''I'' also feel slightly off; Having loose stool; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 09Apr2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to unknown form of anxiety medication. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. Concomitant medications included ethinylestradiol/ norethisterone acetate (LOESTRIN), multivitamin (MANUFACTURER UNKNOWN) and loratadine (CLARITIN); all for an unknown indication from an unknown date and unknown if ongoing. On 11Apr2021, the patient experienced swollen gland in right armpit, nausea and burning sensation in back 3 days later. The patient experienced swollen hands and feet next day (12Apr2021), had tight sensation and discomfort in back of legs, pain in injection site for 2 days. For the last 2 weeks and at the time of reporting, the patient experienced tingling, tightness and heaviness in her feet and lower legs. She also felt slightly off and had loose stool. Therapeutic measures were not taken as a result of reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pain in injection site was resolved on an unknown date in Apr2021, after a duration of 2 days; while that of the tight sensation and discomfort in back of legs/ heaviness in my feet and lower legs, tingling feet, swollen gland in right armpit, nausea, burning sensation in back, swollen hands and feet, also feel slightly off and had loose stool was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.